Literature DB >> 23507772

Adjusting for mortality when identifying risk factors for transitions to mild cognitive impairment and dementia.

Richard J Kryscio1, Erin L Abner, Yushun Lin, Gregory E Cooper, David W Fardo, Gregory A Jicha, Peter T Nelson, Charles D Smith, Linda J Van Eldik, Lijie Wan, Frederick A Schmitt.   

Abstract

Risk factors for mild cognitive impairment (MCI) and dementia are often investigated without accounting for the competing risk of mortality, which can bias results and lead to spurious conclusions, particularly regarding protective factors. Here, we apply a semi-Markov modeling approach to 531 participants in the University of Kentucky Biologically Resilient Adults in Neurological Studies (BRAiNS) longitudinal cohort, over one-third of whom died without transitioning to a cognitively impaired clinical state. A semi-Markov approach enables a statistical study of clinical state transitions while accounting for the competing risk of death and facilitates insights into both the odds that a risk factor will affect clinical transitions as well as the age at which the transition to MCI or dementia will occur. Risk factors assessed in the current study were identified by matching those reported in the literature with the data elements collected on participants. The presence of Type II diabetes at baseline shortens the time it takes cognitively intact individuals to transition to MCI by seven years on average while use of estrogen replacement therapy at enrollment (baseline) decreases the time required to convert from MCI to dementia by 1.5 years. Finally, smoking and being overweight do not promote transitions to impaired states but instead hasten death without a dementia. In contrast, conventional statistical analyses based on Cox proportional hazards models fail to recognize diabetes as a risk, show that being overweight increases the risk of clinical MCI, and that high blood pressure at baseline increases the risk of a dementia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23507772      PMCID: PMC3703851          DOI: 10.3233/JAD-122146

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.160


  29 in total

1.  Treatment of death in the analysis of longitudinal studies of gerontological outcomes.

Authors:  T E Murphy; L Han; H G Allore; P N Peduzzi; T M Gill; H Lin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-10-28       Impact factor: 6.053

2.  A flexible semi-Markov model for interval-censored data and goodness-of-fit testing.

Authors:  Y Foucher; M Giral; J P Soulillou; J P Daures
Journal:  Stat Methods Med Res       Date:  2008-09-02       Impact factor: 3.021

3.  University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology.

Authors:  Frederick A Schmitt; Peter T Nelson; Erin Abner; Stephen Scheff; Gregory A Jicha; Charles Smith; Gregory Cooper; Marta Mendiondo; Deborah D Danner; Linda J Van Eldik; Allison Caban-Holt; Mark A Lovell; Richard J Kryscio
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

4.  Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study.

Authors:  Rita Peila; Beatriz L Rodriguez; Lenore J Launer
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

5.  Risk factors for transitions from normal to mild cognitive impairment and dementia.

Authors:  R J Kryscio; F A Schmitt; J C Salazar; M S Mendiondo; W R Markesbery
Journal:  Neurology       Date:  2006-03-28       Impact factor: 9.910

Review 6.  Preventing Alzheimer's disease and cognitive decline.

Authors:  John W Williams; B L Plassman; J Burke; S Benjamin
Journal:  Evid Rep Technol Assess (Full Rep)       Date:  2010-04

Review 7.  Epidemiology of Alzheimer disease.

Authors:  Richard Mayeux; Yaakov Stern
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

8.  Obesity phenotypes in midlife and cognition in early old age: the Whitehall II cohort study.

Authors:  Archana Singh-Manoux; Sébastien Czernichow; Alexis Elbaz; Aline Dugravot; Séverine Sabia; Gareth Hagger-Johnson; Sara Kaffashian; Marie Zins; Eric J Brunner; Hermann Nabi; Mika Kivimäki
Journal:  Neurology       Date:  2012-08-21       Impact factor: 9.910

9.  Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study.

Authors:  Huibo Shao; John C S Breitner; Rachel A Whitmer; Junmin Wang; Kathleen Hayden; Heidi Wengreen; Chris Corcoran; Joann Tschanz; Maria Norton; Ron Munger; Kathleen Welsh-Bohmer; Peter P Zandi
Journal:  Neurology       Date:  2012-10-24       Impact factor: 9.910

10.  Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.

Authors:  Sally A Shumaker; Claudine Legault; Lewis Kuller; Stephen R Rapp; Leon Thal; Dorothy S Lane; Howard Fillit; Marcia L Stefanick; Susan L Hendrix; Cora E Lewis; Kamal Masaki; Laura H Coker
Journal:  JAMA       Date:  2004-06-23       Impact factor: 56.272

View more
  15 in total

1.  Outcomes after diagnosis of mild cognitive impairment in a large autopsy series.

Authors:  Erin L Abner; Richard J Kryscio; Frederick A Schmitt; David W Fardo; Daniela C Moga; Eseosa T Ighodaro; Gregory A Jicha; Lei Yu; Hiroko H Dodge; Chengjie Xiong; Randall L Woltjer; Julie A Schneider; Nigel J Cairns; David A Bennett; Peter T Nelson
Journal:  Ann Neurol       Date:  2017-03-22       Impact factor: 10.422

2.  Self-reported memory complaints: implications from a longitudinal cohort with autopsies.

Authors:  Richard J Kryscio; Erin L Abner; Gregory E Cooper; David W Fardo; Gregory A Jicha; Peter T Nelson; Charles D Smith; Linda J Van Eldik; Lijie Wan; Frederick A Schmitt
Journal:  Neurology       Date:  2014-09-24       Impact factor: 9.910

3.  Staging cognitive impairment and incidence of dementia.

Authors:  J Santabárbara; R Lopez-Anton; P Gracia-García; C De-la-Cámara; D Vaquero-Puyuelo; E Lobo; G Marcos; L Salvador-Carulla; T Palomo; N Sartorius; A Lobo
Journal:  Epidemiol Psychiatr Sci       Date:  2015-10-15       Impact factor: 6.892

4.  Tobacco Smoking and Dementia in a Kentucky Cohort: A Competing Risk Analysis.

Authors:  Erin L Abner; Peter T Nelson; Gregory A Jicha; Gregory E Cooper; David W Fardo; Frederick A Schmitt; Richard J Kryscio
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

5.  Markov chains and semi-Markov models in time-to-event analysis.

Authors:  Erin L Abner; Richard J Charnigo; Richard J Kryscio
Journal:  J Biom Biostat       Date:  2013-10-25

6.  Multi-state models and missing covariate data: Expectation-Maximization algorithm for likelihood estimation.

Authors:  Wenjie Lou; Lijie Wan; Erin L Abner; David W Fardo; Hiroko H Dodge; Richard J Kryscio
Journal:  Biostat Epidemiol       Date:  2017-04-04

7.  Semi-Markov models for interval censored transient cognitive states with back transitions and a competing risk.

Authors:  Shaoceng Wei; Richard J Kryscio
Journal:  Stat Methods Med Res       Date:  2014-05-11       Impact factor: 3.021

8.  The Statistical Modeling of Aging and Risk of Transition Project: Data Collection and Harmonization Across 11 Longitudinal Cohort Studies of Aging, Cognition, and Dementia.

Authors:  E L Abner; F A Schmitt; P T Nelson; W Lou; L Wan; R Gauriglia; H H Dodge; R L Woltjer; L Yu; D A Bennett; J A Schneider; R Chen; K Masaki; M J Katz; R B Lipton; D W Dickson; K O Lim; L S Hemmy; N J Cairns; E Grant; S L Tyas; C Xiong; D W Fardo; R J Kryscio
Journal:  Obs Stud       Date:  2015-03

9.  Estimation of Multi-state Models with Missing Covariate Values Based on Observed Data Likelihood.

Authors:  Wenjie Lou; Erin L Abner; Lijie Wan; David W Fardo; Richard Lipton; Mindy Katz; Richard J Kryscio
Journal:  Commun Stat Theory Methods       Date:  2018-12-29       Impact factor: 0.863

10.  Type 2 diabetes mellitus is associated with brain atrophy and hypometabolism in the ADNI cohort.

Authors:  Wei Li; Shannon L Risacher; Edgar Huang; Andrew J Saykin
Journal:  Neurology       Date:  2016-07-06       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.